1. FDA Alert Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085845.htm
2. US Food and Drug Administration Meridia (sibutramine hydrochloride monohydrate) 5, 10, and 15 mg Capsules http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm165416.htm
3. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology.,2007
4. Probable migraine in the United States: Results of the American Migraine Prevalence and Prevention (AMPP) study;Silberstein;Cephalalgia.,2007
5. Psychiatric comorbidity of migraine;Hamelsky;Headache.,2006